VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemes
DCF ValuationCalculate intrinsic value of US stocks
Market ValuationBuffett indicator, CAPE & macro gauges
Total ReturnSee dividends + price return history
DCA CalculatorSimulate recurring buys & compounding
Earnings
FAANG & Tech
AAPL vs MSFTNVDA vs AMDGOOGL vs META
Cloud & Cyber
CRM vs NOWCRWD vs PANWSNOW vs DDOG
Consumer & Auto
TSLA vs FAMZN vs WMTNFLX vs DIS
Finance & Crypto
JPM vs BACV vs MACOIN vs MSTR
Pharma & Energy
LLY vs NVOJNJ vs PFEXOM vs CVX
Compare Any Stocks...
WatchlistInsider
ScreenerThemes
Earnings
WatchlistInsider
NBP
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist
NBPNovaBridge Biosciences
$2.02$101M
Overview & Verdict
Overview
Valuation & Forecasts
Valuation ModelsEstimatesDCF Model
Price & Analyst Data
Analyst TargetsPrice HistoryTechnical Analysis
Financial Statements
Income StatementBalance SheetCash FlowRatios & Margins
Performance
P/E HistoryRevenue HistoryEarnings HistoryDividend HistoryTotal Return
Ownership
Holders
HomeStocksNBPQuarterly Financials

NovaBridge Biosciences (NBP) Quarterly Financials

120+ quarters historyFree accessUpdated daily

NovaBridge Biosciences (NBP) quarterly income statement — complete revenue, gross profit & net income history

NBP Income Statement

Income StatementBalance SheetCash FlowRatios
AnnualQuarterly
MetricQ4'25Q3'25Q2'25Q1'25Q4'24Q3'24Q2'24Q1'24Q4'23Q3'23Q2'23Q1'23Q4'22Q3'22Q2'22Q1'22Q4'21Q3'21Q2'21Q1'21
Sales/Revenue00000071.63M0238M-30.5M9.83M9.83M318.68M-136.71M25.93M25.93M35.13M35.13M8.89M8.89M
Revenue Growth %---100%--100%100%628.92%-100%-25.32%77.69%-62.1%-62.1%807.23%-489.2%191.73%191.73%-97.72%386.72%--
Cost of Goods Sold00000000000027.24M013.62M13.62M23.22M23.22M00
COGS % of Revenue------------8.55%-52.52%52.52%66.09%66.09%--
Gross Profit00000071.63M0238M-30.5M9.83M9.83M291.44M-136.71M12.31M12.31M11.91M11.91M8.89M8.89M
Gross Margin %------100%-100%100%100%100%91.45%100%47.48%47.48%33.91%33.91%100%100%
Gross Profit Growth %---100%--100%100%628.92%-100%-18.34%77.69%-20.17%-20.17%2346.92%-1247.85%38.51%38.51%-99.23%65.03%--
Operating Expenses10.42M8.99M7.11M5.27M97.59M12.41M196.19M90.62M412.86M149.38M345.71M345.71M291.44M437.8M422.54M422.54M534.2M534.2M522.25M522.25M
OpEx % of Revenue------273.87%-173.48%-489.82%3517.82%3517.64%91.45%-320.24%1629.6%1629.6%1520.8%1520.82%5875.87%5875.87%
Selling, General & Admin2.46M5.81M3.82M4.49M53.58M7.94M86.74M51.67M311.79M104.01M122.5M122.5M211.65M211.65M196.23M196.23M224.22M224.22M221.25M221.25M
SG&A % of Revenue------121.09%-131.01%-341.07%1246.46%1246.39%66.42%-154.82%756.8%756.8%638.33%638.33%2489.31%2489.31%
Research & Development7.96M3.18M3.29M777K44.01M4.47M109.44M38.95M101.07M45.36M223.22M223.22M79.79M226.14M226.31M226.31M309.98M309.98M296.5M296.5M
R&D % of Revenue------152.78%-42.47%-148.76%2271.36%2271.25%25.04%-165.42%872.8%872.8%882.47%882.49%3335.92%3335.92%
Other Operating Expenses0000000000050001K-500-50050001000K1000K
Operating Income-10.42M-8.99M-7.11M-5.27M-97.59M-12.41M-124.55M-90.62M-174.87M-179.87M-335.89M-335.89M0-574.5M-410.23M-410.23M-522.29M-522.29M-513.36M-513.36M
Operating Margin %-------173.87%--73.48%589.82%-3417.82%-3417.64%-420.24%-1582.12%-1582.12%-1486.89%-1486.92%-5775.87%-5775.87%
Operating Income Growth %89.32%27.58%94.29%94.19%44.19%93.1%62.92%73.02%-68.69%18.12%18.12%100%-10%20.09%20.09%-144.84%-34.49%-67.31%-67.31%
EBITDA-10.39M-8.77M-7.11M-5.27M-97.38M-6.42M-118.56M-84.63M-168.88M-173.54M00-124.8M-568.4M-404.13M-404.13M-518.38M-518.38M-509.99M-509.99M
EBITDA Margin %-------165.51%--70.96%569.05%---39.16%415.78%-1558.59%-1558.59%-1475.76%-1475.78%-5738.01%-5738.01%
EBITDA Growth %89.33%-36.61%94%93.78%42.34%96.3%---35.32%69.47%100%100%75.92%-9.65%20.76%20.76%-144.31%-34.4%-67.6%-67.6%
D&A (Non-Cash Add-back)30.88K216K00213K5.99M5.99M5.99M5.99M6.33M335.89M335.89M-124.8M6.1M6.1M6.1M3.91M3.91M3.36M3.36M
EBIT-10.42M-8.99M-7.11M-5.27M-97.59M-12.41M-124.55M-90.62M-174.87M-179.87M-12.05M-335.89M0-574.5M-410.23M-410.23M-522.29M-522.29M-508.86M-508.86M
Net Interest Income256.18K2.15M1.8M1.87M2.2M2.45M1.92M5.13M2.21M10.37M-18.52M15.15M10.17M10.17M3.28M3.28M5.96M5.96M4.7M4.7M
Interest Income256.18K2.15M1.8M1.87M2.2M2.45M1.92M5.13M2.21M10.37M-18.52M15.15M10.17M10.17M3.28M3.28M5.96M5.96M4.7M4.7M
Interest Expense00000000000000000000
Other Income/Expense6K2.16M1.61M2.12M2.53M-8.08M66.2M20.64M-556.01M-212.84M-50.51M-50.51M566.18M1.38B1.42B1.42B-278.76M-278.76M-280.02M-280.02M
Pretax Income-10.42M-6.83M-5.5M-3.15M-95.07M-20.49M-58.35M-69.98M-730.88M-392.71M-386.4M-386.4M566.18M803.57M1.01B1.01B-801.06M-801.05M-793.38M-793.38M
Pretax Margin %-------81.46%--307.1%1287.73%-3931.8%-3931.61%177.66%-587.79%3895.35%3895.35%-2280.49%-2280.52%-8926.39%-8926.39%
Income Tax0000-84.22M06.63M0-384.43M-149.07M0-1K1.3B1.53B1.53B1.53B-173.53M-173.52M-255.14M-255.14M
Effective Tax Rate %0%0%0%0%88.59%0%-11.36%0%52.6%37.96%0%0%228.98%190.87%151.82%151.82%21.66%21.66%32.16%32.16%
Net Income-4.4M-6.83M-5.5M-3.15M-9.06M-20.49M-33.04M20.84M-346.45M-243.64M-386.4M-386.4M-730.23M-730.23M-523.43M-523.43M-627.53M-627.53M-538.24M-538.24M
Net Margin %-------46.13%--145.57%798.92%-3931.8%-3931.6%-229.14%534.15%-2018.7%-2018.7%-1786.49%-1786.51%-6055.81%-6055.81%
Net Income Growth %51.43%66.68%83.34%-115.11%97.38%91.59%91.45%105.39%52.56%66.63%26.18%26.18%-16.37%-16.37%2.75%2.75%-160.25%-5236.11%-84.69%-84.69%
Net Income (Continuing)-10.42M-6.83M-5.5M-3.15M-10.84M-20.49M-64.98M-69.98M-346.45M-243.64M-386.4M-386.4M-730.23M-730.23M-523.43M-523.43M-627.53M-627.53M-538.24M-538.24M
Discontinued Operations00001000K01000K1000K000000000000
Minority Interest00000000000000000000
EPS (Diluted)-0.09-0.16-0.07-0.28-0.11-0.250.30-0.85-4.16-4.16-0.74-4.65-8.81-8.81-6.37-6.37-7.98-7.98-7.34-7.34
EPS Growth %19.27%36%-122.53%67.06%97.36%93.99%140.54%81.72%52.78%52.78%88.38%27%-10.4%-10.4%13.22%13.22%-154.29%-4090%-33.45%-33.45%
EPS (Basic)-0.09-0.16-0.07-0.28-0.11-0.250.30-0.21-4.16-4.16-0.74-4.65-8.81-8.81-6.37-6.37-8.00-8.00-7.34-7.34
Diluted Shares Outstanding50.17M43.89M81.7M81.6M81.5M81.5M80.93M80.87M83.29M83.29M83.17M83.17M82.87M82.87M82.11M82.11M78.52M78.52M73.4M73.4M
Basic Shares Outstanding50.17M43.89M81.7M81.6M81.5M81.5M81.78M82.06M83.21M83.21M83.17M83.17M82.87M82.87M82.11M82.11M78.47M78.47M73.4M73.4M
Dividend Payout Ratio--------------------